West Pharmaceutical Services (WST) to Release Quarterly Earnings on Thursday

West Pharmaceutical Services (NYSE:WST) is scheduled to announce its earnings results before the market opens on Thursday, July 25th. Analysts expect the company to announce earnings of $1.78 per share for the quarter. West Pharmaceutical Services has set its FY 2024 guidance at 7.630-7.880 EPS.Investors interested in listening to the company’s conference call can do so using this link.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, April 25th. The medical instruments supplier reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.29 by $0.27. West Pharmaceutical Services had a net margin of 19.42% and a return on equity of 20.57%. The business had revenue of $695.40 million during the quarter, compared to analysts’ expectations of $670.62 million. During the same period last year, the company posted $1.98 EPS. The company’s revenue was down 3.0% on a year-over-year basis. On average, analysts expect West Pharmaceutical Services to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

West Pharmaceutical Services Trading Down 0.6 %

Shares of WST opened at $316.18 on Wednesday. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.61 and a quick ratio of 1.95. The firm has a 50 day simple moving average of $327.59 and a 200-day simple moving average of $357.00. West Pharmaceutical Services has a 1-year low of $310.00 and a 1-year high of $415.73. The stock has a market cap of $23.03 billion, a price-to-earnings ratio of 41.71, a price-to-earnings-growth ratio of 5.64 and a beta of 1.00.

West Pharmaceutical Services Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, August 7th. Shareholders of record on Wednesday, July 31st will be paid a $0.20 dividend. The ex-dividend date of this dividend is Wednesday, July 31st. This represents a $0.80 annualized dividend and a yield of 0.25%. West Pharmaceutical Services’s payout ratio is currently 10.55%.

Insiders Place Their Bets

In other West Pharmaceutical Services news, SVP Silji Abraham sold 1,800 shares of West Pharmaceutical Services stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $330.78, for a total value of $595,404.00. Following the completion of the sale, the senior vice president now directly owns 2,860 shares of the company’s stock, valued at approximately $946,030.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CEO Eric Mark Green sold 66,000 shares of the business’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $366.65, for a total transaction of $24,198,900.00. Following the completion of the sale, the chief executive officer now directly owns 152,908 shares of the company’s stock, valued at approximately $56,063,718.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Silji Abraham sold 1,800 shares of the business’s stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $330.78, for a total transaction of $595,404.00. Following the sale, the senior vice president now directly owns 2,860 shares of the company’s stock, valued at $946,030.80. The disclosure for this sale can be found here. 0.53% of the stock is owned by corporate insiders.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.